Key result
Class III antiarrhythmics linked to higher sinus rhythm maintenance after electrical cardioversion.
Why the study?
Long term success rates and factors influencing persistence of sinus rhythm after a first electrical cardioversion for atrial fibrillation are not well defined.
What clinical, functional, and pharmacological factors predict the maintenance of sinus rhythm after a first electrical cardioversion for atrial fibrillation?
Observational (n=85)
What clinical, functional, and pharmacological factors predict the maintenance of sinus rhythm after a first electrical cardioversion for atrial fibrillation?
Class III antiarrhythmic drugs, shorter duration of preceding atrial fibrillation, and younger age are key determinants of long-term sinus rhythm maintenance after first electrical cardioversion, whereas echocardiographic parameters are not.
Answers are grounded in this paper and cite their sources.
Analysis of predictors after cardioversion for longstanding AF; leaves open whether targeted strategies improve sinus rhythm maintenance.
It is conventionally thought that electrical cardioversion in patients with atrial fibrillation (AF) of longstanding duration or with a large left atrial diameter, only seldom results in long term success. Recurrence is common, although antiarrhythmic drugs often effectively decrease the number and duration of recurrent AF episodes. We analysed clinical, functional and pharmacological variables which could possibly influence the long term outcome after a first electrical cardioversion for AF in a retrospective study on 85 patients. Univariate and multivariate analysis was used to identify factors predicting maintenance of sinus rhythm at 100 days, and absence of recurrence during the entire follow-up. In univariate analysis, the only significant predictor for maintenance of sinus rhythm at 100 days was the duration of the preceding AF episode. Multivariate analysis with persistence of sinus rhythm at 100 days as endpoint confirmed this as a prognostic factor (p < 0.03), but sotalol treatment also contributed to maintenance of sinus rhythm (p < 0.05). When considering the entire observation period, class III antiarrhythmic drugs, i.e. sotalol and amiodarone, were useful in preventing recurrence (p < 0.01 and < 0.02). High age (above 75 years) was a predictor of recurrence. In conclusion, class III antiarrhythmic drugs, the duration of atrial fibrillation and high age were the most important determinants of long term outcome, while echocardiographic parameters and the presence of heart disease played no role.
No takes yet. Share an insight, caveat, or question.
Duytschaever et al. (1998) conducted an observational in Atrial fibrillation (n=85). Class III antiarrhythmic drugs, duration of atrial fibrillation, and age was evaluated on Maintenance of sinus rhythm at 100 days (p=<0.03). Class III antiarrhythmic drugs, duration of atrial fibrillation, and age <75 years predicted long-term sinus rhythm maintenance after first electrical cardioversion.
Synapse has enriched 10 related papers. Consider them for comparative context: